Skip to main content
. 2020 Sep 14;21:234. doi: 10.1186/s12931-020-01490-1

Fig. 1.

Fig. 1

Extent of HSP47 immunostaining in lung cancer (a) score 0: no immunostaining; b 1: weak staining; c 2: moderate staining; and d 3: strong staining. Fibroblasts in cancer stroma (e) Hematoxylin-Eosin staining, (f) HSP47 immunostaining